A Pilot Study of the Safety and Efficacy of Abatacept Injections in the Treatment of Mucocutaneous Manifestations of Behcet's Syndrome
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 01 Feb 2017
At a glance
- Drugs Abatacept (Primary)
- Indications Behcet's syndrome; Genital ulcer; Oral ulcer
- Focus Therapeutic Use
- 23 Jan 2017 Planned End Date changed from 1 Feb 2017 to 1 Feb 2018.
- 23 Jan 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
- 23 Jan 2017 Status changed from recruiting to active, no longer recruiting.